Table 1.
Demographics and Clinical Characteristics of Glaucoma Patients Underwent Minimally Invasive Glaucoma Surgery
| Parameters | MIGS | KDB | iStent | GATT | iStent Inject | |
|---|---|---|---|---|---|---|
| Eyes (n) | 93 | 50 | 13 | 7 | 23 | |
| Age (years) | ||||||
| 20 to 40 | 2.6% (2) | |||||
| 41 to 60 | 21.8% (17) | |||||
| 61 to 70 | 44.9% (35) | |||||
| >70 | 30.8% (24) | |||||
| Gender | ||||||
| Male %(n) | 51.3(40) | |||||
| Female %(n) | 48.7(38) | |||||
| Diagnosis | ||||||
| POAG | 71.0% (66) | 54.0% (27) | 92.3% (12) | 100.0% (7) | 87.0% (20) | |
| SOAG | 14.0% (13) | 18.0% (9) | 7.7% (1) | 0% (0) | 13.0% (3) | |
| PACG | 10.8% (10) | 20.0% (10) | 0% (0) | 0% (0) | 0% (0) | |
| NTG | 1.1% (1) | 2.0% (1) | 0% (0) | 0% (0) | 0% (0) | |
| PXF | 3.2% (3) | 6.0% (3) | 0% (0) | 0% (0) | 0% (0) | |
| Preoperative AGM | ||||||
| 0 | 2.2% (2) | 2.0% (1) | 7.7% (1) | 0% (0) | 0% (0) | |
| 1 | 23.7% (22) | 12.0% (6) | 30.8% (4) | 0% (0) | 52.2% (12) | |
| 2 | 19.4% (18) | 12.0% (6) | 38.5% (5) | 28.6% (2) | 21.7% (5) | |
| 3 | 19.4% (18) | 20.0% (10) | 15.4% (2) | 0% (0) | 26.1% (6) | |
| >3 | 35.5% (33) | 54.0% (27) | 7.7% (1) | 71.4% (5) | 0% (0) | |
| Postoperative AGM | ||||||
| 0 | 51.6% (48) | 42.0% (21) | 38.5% (5) | 42.9% (3) | 82.6% (19) | |
| 1 | 17.2% (16) | 10.0% (5) | 46.2% (6) | 14.3% (1) | 17.4% (4) | |
| 2 | 14.0% (13) | 20.0% (10) | 0% (0) | 42.9% (3) | 0% (0) | |
| 3 | 11.8% (11) | 22.0% (11) | 0% (0) | 0% (0) | 0% (0) | |
| >3 | 5.4% (5) | 6.0% (3) | 15.4% (2) | 0% (0) | 0% (0) |
Abbreviations: MIGS, minimally invasive glaucoma surgery; KDB, Kahook Dual Blade; GATT, gonioscopy-assisted transluminal trabeculotomy; POAG, primary open-angle glaucoma; SOAG, secondary open-angle glaucoma; PACG, primary angle-closure glaucoma; NTG, normal-tension glaucoma; PXF, pseudoexfoliation glaucoma; AGM, anti-glaucoma medication.